Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F23229)
Formulation Name
Migalastat 123 mg capsule
Company
Amicus Therapeutics Us
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Migalastat
DMFIQ2H
Fabry disease
5C56.01
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
FD&C blue no. 2
E00446
2723854
Colorant
Ferric oxide black
E00522
16211978
Colorant
Gelatin
E00630
Not Available
Other agent
Magnesium stearate
E00208
11177
lubricant
Potassium hydroxide
E00233
14797
Alkalizing agent
Pregelatinized starch
E00674
Not Available
Binding agent; Diluent; Disintegrant
Shellac
E00695
Not Available
Coating agent; Film/membrane-forming agent; Microencapsulating agent; Modified-release agent
Titanium dioxide
E00322
26042
Coating agent; Colorant; Opacifying agent
--------------------